Evidence map›Paper›PMID 39477833›Full record

ArticleRadiologie (Heidelberg, Germany)2024

Implementing verifiable oncological imaging by quality assurance and optimization (i‑Violin) : Protocol for a European multicenter study.

Tobias Jorg, Moritz C Halfmann, Lukas Müller, Fabian Stoehr, Peter Mildenberger, Monika Hierath, Graciano Paulo, Joana Santos, John Damilakis, Ivana Kralik and 9 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Radiologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Tobias JorgDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckst. 1, 55131, Mainz, Germany.
Moritz C HalfmannDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckst. 1, 55131, Mainz, Germany. moritz.halfmann@unimedizin-mainz.de.
Lukas MüllerDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckst. 1, 55131, Mainz, Germany.
Fabian StoehrDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckst. 1, 55131, Mainz, Germany.
Peter MildenbergerDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckst. 1, 55131, Mainz, Germany.
Monika HierathEuropean Institute for Biomedical Imaging Research (EIBIR), Am Gestade 1, 1010, Vienna, Austria.
Graciano PauloCoimbra Health School, Polytechnic Institute of Coimbra, Rua 5 de Outubro-S. Martinho do Bispo, Apartado 7006, 3046-854, Coimbra, Portugal.
Joana SantosCoimbra Health School, Polytechnic Institute of Coimbra, Rua 5 de Outubro-S. Martinho do Bispo, Apartado 7006, 3046-854, Coimbra, Portugal.
John DamilakisSchool of Medicine, University of Crete, 2208, 71003, Iraklion, Crete, Greece.
Ivana KralikDubrava University Hospital, Avenija Gojka Suska 6, 10000, Zagreb, Croatia.
Boris BrkljacicDubrava University Hospital, Avenija Gojka Suska 6, 10000, Zagreb, Croatia.
Danijel CvetkoDubrava University Hospital, Avenija Gojka Suska 6, 10000, Zagreb, Croatia.
Dimitrij KuhlejiUniversity Medical Centre Ljubljana, Ljubljana, Slovenia.
Hilde BosmansMedical Imaging Research Center, Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Dimitar PetrovMedical Imaging Research Center, Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Shane FoleyRadiography & Diagnostic Imaging, School of Medicine University College Dublin, Dublin, Ireland.
Paula ToroiSTUK-Radiation and Nuclear Safety Authority, Jokiniemenkuja 1, 01370, Vantaa, Finland.
Jonathan P McNultyRadiography & Diagnostic Imaging, School of Medicine University College Dublin, Dublin, Ireland.
Christoph HoeschenInstitute of Medical Technology, Faculty for electrical engineering and Information Technology, Otto-von-Guericke-University Magdeburg, Otto-Hahn-Str. 2, 39106, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvanced imaging techniques play a pivotal role in oncology. A large variety of computed tomography (CT) scanners, scan protocols, and acquisition techniques have led to a wide range in image quality and radiation exposure. This study aims at implementing verifiable oncological imaging by quality assurance and optimization (i-Violin) through harmonizing image quality and radiation dose across Europe.

methodsThe 2‑year multicenter implementation study outlined here will focus on CT imaging of lung, stomach, and colorectal cancer and include imaging for four radiological indications: diagnosis, radiation therapy planning, staging, and follow-up. Therefore, 480 anonymized CT data sets of patients will be collected by the associated university hospitals and uploaded to a repository. Radiologists will determine key abdominopelvic structures for image quality assessment by consensus and subsequently adapt a previously developed lung CT tool for the objective evaluation of image quality. The quality metrics will be evaluated for their correlation with perceived image quality and the standardized optimization strategy will be disseminated across Europe.

resultsThe results of the outlined study will be used to obtain European reference data, to build teaching programs for the developed tools, and to create a culture of optimization in oncological CT imaging.

conclusionThe study protocol and rationale for i‑Violin, a European approach for standardization and harmonization of image quality and optimization of CT procedures in oncological imaging, is presented. Future results will be disseminated across all EU member states, and i‑Violin is thus expected to have a sustained impact on CT imaging for cancer patients across Europe.

Indexed as

Quality Assurance, Health CareTomography, X-Ray ComputedEuropeHumansLung NeoplasmsMulticenter Studies as TopicNeoplasmsRadiation DosageDosimetryEducationImaging standardizationOncologyRadiation protectionTraining

Identifiers

PMID39477833
PMCPMC11602843

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.